// App-Quantinova.ai

: Glomerular Disease in Women

Researchers

Presenter

  • Kate Wiles

Principal Investigators

  • Liz Lightstone

Medical Centers

  • Obstetric Nephrology, Guy’s and St. Thomas’ NHS Trust and King’s College London, London, UK

  • Division of Immunology and Inflammation, Department of Medicine, Imperial College London, Hammersmith Campus, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 79A

  • Creatinine

Drug/Treatment

  • Norelgestromin / ethinyl estradiol

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Erythropoietin

  • Mycophenolic acid

  • Oraprine

  • Methotrexate

  • Calcifediol

  • Pravastatin sodium

  • Angiotensin II

  • Cinacalcet hydrochloride

  • Methyldopa

  • Nifedipine

  • Tacrolimus

  • Ergocalciferol

  • Calcitriol

  • Amlodipine

  • Alora

  • Captopril

  • etonogestrel implant

  • Labetalol

  • labetalol Intravenous

  • Enalapril maleate

  • Rituximab

  • Atenolol

  • L-Tyrosine

  • Aspirin

  • Albyl-E

  • Heparin

  • Levonorgestrel

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Single Arm

  • Prospective

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved